https://scholars.lib.ntu.edu.tw/handle/123456789/638350
標題: | The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer | 作者: | Yeo, Xun Hui Sundararajan, Vignesh Wu, Zhengwei Phua, Zi Jin Cheryl Ho, Yin Ying Peh, Kai Lay Esther Chiu, Yi-Chia Tan, Tuan Zea Kappei, Dennis Ho, Ying Swan Tan, David Shao Peng Tam, Wai Leong RUBY YUN-JU HUANG |
公開日期: | 22-六月-2023 | 卷: | 6 | 期: | 1 | 來源出版物: | Communications biology | 摘要: | AXL is a receptor tyrosine kinase that is often overexpressed in cancers. It contributes to pathophysiology in cancer progression and therapeutic resistance, making it an emerging therapeutic target. The first-in-class AXL inhibitor bemcentinib (R428/BGB324) has been granted fast track designation by the U.S. Food and Drug Administration (FDA) in STK11-mutated advanced metastatic non-small cell lung cancer and was also reported to show selective sensitivity towards ovarian cancers (OC) with a Mesenchymal molecular subtype. In this study, we further explored AXL's role in mediating DNA damage responses by using OC as a disease model. AXL inhibition using R428 resulted in the increase of DNA damage with the concurrent upregulation of DNA damage response signalling molecules. Furthermore, AXL inhibition rendered cells more sensitive to the inhibition of ATR, a crucial mediator for replication stress. Combinatory use of AXL and ATR inhibitors showed additive effects in OC. Through SILAC co-immunoprecipitation mass spectrometry, we identified a novel binding partner of AXL, SAM68, whose loss in OC cells harboured phenotypes in DNA damage responses similar to AXL inhibition. In addition, AXL- and SAM68-deficiency or R428 treatment induced elevated levels of cholesterol and upregulated genes in the cholesterol biosynthesis pathway. There might be a protective role of cholesterol in shielding cancer cells against DNA damage induced by AXL inhibition or SMA68 deficiency. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/638350 | ISSN: | 2399-3642 | DOI: | 10.1038/s42003-023-05045-0 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。